LPCAT2 and metabolic dysfunction-associated steatohepatitis: Because AA‐containing PCs are typically periportal in human liver, an enrichment of LPCAT2 and AA in zone 3 would contribute to a loss of zonation for this lipid, which we observed in NASH.